Cargando…

Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies

Baclofen is a racemic mixture that is commonly used for the treatment for spasticity. However, the optimal dose and dosing interval to achieve effective cerebral spinal fluid (CSF) concentrations of baclofen are not known. Moreover, it is unclear if there are differences in the ability of R- or S-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qingfeng, Chhonker, Yashpal S., McLaughlin, Matthew J., Murry, Daryl J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024189/
https://www.ncbi.nlm.nih.gov/pubmed/31936209
http://dx.doi.org/10.3390/molecules25020250
_version_ 1783498377486401536
author He, Qingfeng
Chhonker, Yashpal S.
McLaughlin, Matthew J.
Murry, Daryl J.
author_facet He, Qingfeng
Chhonker, Yashpal S.
McLaughlin, Matthew J.
Murry, Daryl J.
author_sort He, Qingfeng
collection PubMed
description Baclofen is a racemic mixture that is commonly used for the treatment for spasticity. However, the optimal dose and dosing interval to achieve effective cerebral spinal fluid (CSF) concentrations of baclofen are not known. Moreover, it is unclear if there are differences in the ability of R- or S-baclofen to cross the blood–brain barrier and achieve effective CSF concentrations. We have validated a liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) method with improved selectivity and sensitivity for the simultaneous quantitation of R- and S-baclofen and metabolites in plasma and CSF. Protein precipitation by acetonitrile was utilized to obtain an acceptable recovery of the analytes. The detection and separation of analytes was achieved on a 48 °C-heated Crownpak CR(+) column (150 mm × 4.0 mm, 5μ) with elution using 0.4% formic acid (FA) in water and 0.4% FA in acetonitrile as the mobile phase running at a flow rate of 1.0 mL/min. Accurate quantitation was assured by using this MS/MS method with atmospheric pressure chemical ionization in multiple reaction monitoring (MRM) mode. Therefore, this method is enantioselective, accurate, precise, sensitive, reliable, and linear from 1 to 1500 ng/mL for baclofen and 2 to 4000 ng/mL for the metabolites. An additional method was developed to separate racemic baclofen 3-(4-chlorophenyl)-4 hydroxybutyric acid metabolites for individual concentration determination. Both validated methods were successfully applied to a clinical pharmacokinetic human plasma and CSF study evaluating the disposition of baclofen and metabolites.
format Online
Article
Text
id pubmed-7024189
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70241892020-03-19 Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies He, Qingfeng Chhonker, Yashpal S. McLaughlin, Matthew J. Murry, Daryl J. Molecules Article Baclofen is a racemic mixture that is commonly used for the treatment for spasticity. However, the optimal dose and dosing interval to achieve effective cerebral spinal fluid (CSF) concentrations of baclofen are not known. Moreover, it is unclear if there are differences in the ability of R- or S-baclofen to cross the blood–brain barrier and achieve effective CSF concentrations. We have validated a liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) method with improved selectivity and sensitivity for the simultaneous quantitation of R- and S-baclofen and metabolites in plasma and CSF. Protein precipitation by acetonitrile was utilized to obtain an acceptable recovery of the analytes. The detection and separation of analytes was achieved on a 48 °C-heated Crownpak CR(+) column (150 mm × 4.0 mm, 5μ) with elution using 0.4% formic acid (FA) in water and 0.4% FA in acetonitrile as the mobile phase running at a flow rate of 1.0 mL/min. Accurate quantitation was assured by using this MS/MS method with atmospheric pressure chemical ionization in multiple reaction monitoring (MRM) mode. Therefore, this method is enantioselective, accurate, precise, sensitive, reliable, and linear from 1 to 1500 ng/mL for baclofen and 2 to 4000 ng/mL for the metabolites. An additional method was developed to separate racemic baclofen 3-(4-chlorophenyl)-4 hydroxybutyric acid metabolites for individual concentration determination. Both validated methods were successfully applied to a clinical pharmacokinetic human plasma and CSF study evaluating the disposition of baclofen and metabolites. MDPI 2020-01-08 /pmc/articles/PMC7024189/ /pubmed/31936209 http://dx.doi.org/10.3390/molecules25020250 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
He, Qingfeng
Chhonker, Yashpal S.
McLaughlin, Matthew J.
Murry, Daryl J.
Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies
title Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies
title_full Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies
title_fullStr Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies
title_full_unstemmed Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies
title_short Simultaneous Quantitation of S(+)- and R(−)-Baclofen and Its Metabolite in Human Plasma and Cerebrospinal Fluid using LC–APCI–MS/MS: An Application for Clinical Studies
title_sort simultaneous quantitation of s(+)- and r(−)-baclofen and its metabolite in human plasma and cerebrospinal fluid using lc–apci–ms/ms: an application for clinical studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024189/
https://www.ncbi.nlm.nih.gov/pubmed/31936209
http://dx.doi.org/10.3390/molecules25020250
work_keys_str_mv AT heqingfeng simultaneousquantitationofsandrbaclofenanditsmetaboliteinhumanplasmaandcerebrospinalfluidusinglcapcimsmsanapplicationforclinicalstudies
AT chhonkeryashpals simultaneousquantitationofsandrbaclofenanditsmetaboliteinhumanplasmaandcerebrospinalfluidusinglcapcimsmsanapplicationforclinicalstudies
AT mclaughlinmatthewj simultaneousquantitationofsandrbaclofenanditsmetaboliteinhumanplasmaandcerebrospinalfluidusinglcapcimsmsanapplicationforclinicalstudies
AT murrydarylj simultaneousquantitationofsandrbaclofenanditsmetaboliteinhumanplasmaandcerebrospinalfluidusinglcapcimsmsanapplicationforclinicalstudies